PREGABALINE 300mg

Description

Pregabline 300mg (Pregabaline Mylan) is used to treat long-lasting pain caused by damage to the nerves. Different pathologies such as diabetes or shingles can induce peripheral neuropathic pain. Painful manifestations can be described as sensations of heat, burning, stabbing pain, throbbing, stabbing, searing pain, cramping, soreness, tingling, numbness, pinching, and needle strokes. Peripheral and central neuropathic pain can also be associated with mood changes, sleep disturbances, fatigue, and can impact physical and social functioning, and overall quality of life.

PREGABALINE 300mg is used to treat a special type of epilepsy (partial seizures with or without secondary generalization) in adults. Your doctor will prescribe Pregabline Biogran to help treat your epilepsy when your current treatment is not completely controlling your seizures. You must take Pregabline Biogran in combination with your current treatment. Pregabline Biogran must not be used alone, but must always be used in combination with other antiepileptic therapy. PREGABALINE 300mg  is used to treat Generalized Anxiety Disorder (GAD). Symptoms of GAD include prolonged excessive anxiety and worry that are difficult to control. GAD can also induce restlessness or a feeling of excitement or nervousness, a feeling of being easily tired, difficulty concentrating or memory lapses, irritability, muscle tension, or trouble sleeping. This is different from the stresses and strains of everyday life. 

Using Pregabline Biogran

PREGABALINE 300mg (Pregabaline Mylan) may cause dizziness, drowsiness and decreased concentration. You should not drive, use complex machinery, or engage in potentially hazardous activities until it is determined whether this medicine affects your ability to perform such activities. Safety and efficacy in children and adolescents (less than 18 years of age) have not been established. The pregabalin should therefore not be used in this population.

Some patients taking PREGABALINE 300mg reported symptoms suggestive of allergic reaction. It consisted of swelling of the face, lips, tongue and throat as well as a diffuse skin rash. Contact your doctor immediately if you experience any of these reactions.

PREGABALINE 300mg treatment can be started at a dose of 150 mg per day given as two or three divided doses. Based on individual patient response and tolerability, the dose may be increased to 300 mg per day after an interval of 3 to 7 days, and if needed, to a maximum dose of 600 mg per day after an additional 7-day interval. Pregabalin treatment can be started with a dose of 150 mg per day given as two or three divided doses. Based on individual patient response and tolerability, the dose may be increased to 300 mg per day after 1 week. The maximum dose of 600 mg per day may be achieved after an additional week.

Pregabaline Mylan treatment can be started with a dose of 150 mg per day. Based on individual patient response and tolerability, the dose of PREGABALINE 300mg may be increased to 300 mg per day after 1 week. Following an additional week the dose may be increased to 450 mg per day. The maximum dose of PREGABALINE 300mg per day may be achieved after an additional week. Pregabalin is removed effectively from plasma by haemodialysis (50% of drug in 4 hours). For patients receiving haemodialysis, the pregabalin daily dose should be adjusted based on renal function. In addition to the daily dose, a supplementary dose should be given immediately following every 4 hour haemodialysis treatment